ICEMVO 2024 Annual Fee has been decided by ICEMVO Board of Directors and, as was the case for previous year, there will be an reduction in fees, compared to current year. Additionally, sales categories by turnover, as presented in Icelandic Drug Market (IDM, SEPT MAT), have been revised and increased to ensure that smaller MAHs continue to pay lower fees. This reflects the Board committment to not create barriers for entry to market for medicines in Iceland.
ICEMVO 2024 Annual Fee:
- 3,160 € for MAH with sales turnover above 142,000 € (2023 SEPT MAT)
- 970 € for MAH with sales turnover between 41,000 € to 142,000 € (2023 SEPT MAT)
- 290 € for MAH with sales below 41,000 € (2023 SEPT MAT).
For any further information please contact ICEMVO via email firstname.lastname@example.org